Lexeo Therapeutics, Inc. (NASDAQ: LXEO) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT LEXEO THERAPEUTICS, INC.

Lexeo Therapeutics, Inc. (NASDAQ: LXEO)
Listen to this Section


$5.78
+0.0070 ( -1.25% ) 197.1K

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

Market Data


Open $5.78
Previous Close $5.77
Volume 197.1K
Market Cap $193.50M
Day Range $5.46 - $6.04
52 Week Range $4.67 - $19.50
Shares Outstanding 33.08M
Change % -1.25%
Net Change ▲ 0.0070
Insider Ownership 0.00%
Exchange NASDAQ
Sector Miscellaneous
Industry None
IPO Year 2023
Country United States
Under Writer J.P. Morgan, Leerink Partners, Stifel, RBC Capital Markets, Chardan Capital Markets, more

Insider Ownership Transactions

Total Amount Purchased: 4,198,952.00

Date Type Amount Purchased Purchaser
2024-11-26 Buy 15000.00 CHOLMONDELEY PAULA H
2024-08-13 Sale -5000.00 Townsend Richard Nolan
2024-07-12 Sale -5000.00 Townsend Richard Nolan
2024-07-08 Sale -36000.00 Van Hauwermeiren Timothy
2024-06-27 Sale -18000.00 Agger Mette Kirstine
2024-06-27 Sale -18000.00 DIAZ REINALDO M
2024-06-27 Sale -18000.00 CHOLMONDELEY PAULA H
2024-06-27 Sale -18000.00 COOPERSTONE BRENDA
2024-06-27 Sale -18000.00 Altschuler Steven
2024-06-14 Sale -31250.00 Otero Jose Manuel

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 2 Dec 27, 2024
8-k 8K-related 13 Dec 19, 2024
4 Insider transactions 1 Dec 12, 2024
4 Insider transactions 1 Nov 26, 2024
3 Insider transactions 2 Nov 13, 2024
8-k 8K-related 13 Nov 13, 2024
4 Insider transactions 1 Nov 13, 2024
4 Insider transactions 1 Nov 13, 2024
10-q Quarterly Reports 64 Nov 13, 2024
8-k 8K-related 34 Oct 30, 2024

Latest News


× Before browsing our site, please accept our cookies policy